Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients

Journal of Sex and Marital Therapy

Volumn 23, Issue 3, 1997, Pages 165-175

  Ashton, Adam Keller ^a   Hamer, Robert ^a   Rosen, Raymond C ^a  

^a Society for Sex Therapy and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CYPROHEPTADINE; SEROTONIN UPTAKE INHIBITOR; YOHIMBINE;

ADULT; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOANALYSIS; SEROTONIN UPTAKE; SEXUAL DYSFUNCTION; TREATMENT PLANNING;

ADULT; AMANTADINE; AMBULATORY CARE; APHRODISIACS; CYPROHEPTADINE; DOPAMINE AGENTS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOHIMBINE;

EID: 0030732664     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239708403922     Document Type: Article

References (34)

1. Cohn JB, Wilcox C: A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry, 46: 26-31, 1985.
2. Reimherr FW, Byerley WF, Ward MF, Lebeque BJ, Wender PH: Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder Psychopharmacol Bull, 24: 200-205, 1988.
3. Cohn JB, Wilcox C: Paroxetine in major depression: A double-blind trial with imipramine and placebo. J Clin Psychiatry, 53: 52-56, 1992.
4. Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C: The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. J Clin Psychiatry, 53: 30-32, 1992.
5. Schweizer E, Feighner J, Mandos L, Rickels K: Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry, 55: 104-108, 1994.
6. Rosenthal J, Hemlock C, Hellerstein DJ, Yanowitch P, Kasch K, Schupak C, Samstag L, Winston A: A preliminary study of serotonergic antidepressants in treatment of dysthymia. Prog Neuro-Psyckopharmacol Biol Psychiatry, 16: 933-941, 1992.
7. Hellerstein D, Yanowitch P, Rosenthal JL A randomized double-blind study of fluoxetine versus placebo in treatment of dysthymia. Am J Psychiatry, 150: 1169-1175, 1993.
8. Fontaine F, Chouinard G: An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. J Clin Psychopharmacol, 6: 98-101, 1986.
9. Turner SM, Jacob RG, Beidel DC, Himmelhoch J: Fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol, 5: 207-212, 1985.
10. Dominguez RA: Serotonergic antidepressants and their efficacy in obsessive-compulsive disorder. J Clin Psychiatry, 53: 56-59, 1992.
11. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
12. Patterson WM: Fluoxetine-induced sexual dysfunction. J Clin Psychiatry, 54:71, 1993.
13. Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF: Fluoxetine-induced sexual dysfunction. J Clin Psychiatry, 51: 25-27, 1990.
14. McCormick S, Olin J, Brotman AW: Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry, 51: 383-384, 1990.
15. Feder R: Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry, 52:163-164, 1991.
16. Jacobsen FM: Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry, 53: 119-122, 1992.
17. Hollander E, McCarley A: Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry, 53: 207-209, 1992.
18. Balogh S, Hendricks SE, KangJ: Treatment of fluoxetine-induced anorgasmia with amantadine. J Clin Psychiatry, 53: 212-213, 1992.
19. Shrivastava RK, Shrivastava S, Overweg N, Schmitt M: Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol, 15(1): 83-84, 1995.
20. Steele TE, Howell EF: Cyproheptadine for imipramine-induced anorgasmia. J Clin Psychopharmacol, 6: 326-327, 1986.
21. Reid K, Morales A, Harris C, Surridge DH, Condra M, Owen J, Fenemore J: Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet, 2: 421-423, 1987.
22. Morales A, Condra M., Owen JA, Surridge DH, Fenemore J, Harris C: Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol, 137: 1168-1172, 1987.
23. Ashton AK: Yohimbine in the treatment of male erectile dysfunction. Am J Psychiatry, 151(9): 1397, 1994.
24. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry, 152(10): 1514-1516, 1995.
25. Norden MD: Buspirone treatment of sexual dysfunction associated with SSRI’s. Depression, 2:109-112, 1994.
26. Labbate LA, Pollack MH: Treatment of fluoxetine-induced sexual dysfunction with buproprion: A case report. Ann Clin Psychiatry, 6(1): 13-15, 1994.
27. Bartlik BD, Kaplan P, Kaplan HS: Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin reuptake inhibitors. J Sex Marital Ther, 4: 264-271, 1995.
28. Goldbloom DS, Kennedy SH: Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. J Clin Psychiatry, 52: 261-262, 1991.
29. Burnap DW, Golden JS: Sexual problems in medical practice. J Med Educ, 42: 673-686, 1967.
30. Monteiro WO, Noshirvani HF, Marks IM, Lelliot PT: Anorgasmia from clomipramine in obsessive-compulsive disorder: A controlled trial. Br J Psychiatry, 151: 107-112, 1987.
31. Gitlin M: Psychotropic medications and their effects on sexual function: Diagnosis, biology and treatment approaches. J Clin Psychiatry, 55: 406-413, 1994.
32. Segraves RT: Overview of sexual dysfunction complicating the treatment of depression [Monograph]. J Clin Psychiatry, 10(2): 4-10, 1992.
33. Smith ER, Maurice J, Richardson R, Walter T, Davidson JM: Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior. Pharmacol Biochem Behav, 36: 713-717, 1990.
34. Clark JT, Peroutka SJ, Ciaranello RD, Smith ER, Davidson JM: Central effects of RDS-127: Sexual behavior after intracerebroventricular administration and in vitro binding studies. Behav Brain Res, 19: 251-260, 1985.